7 completed, 6 unknown, 1 active not recruiting, 1 recruiting. 17 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 17 | Completed 7, Unknown 6, Active not recruiting 1, Recruiting 1, Terminated 1, Withdrawn 1 |
Follow FOLFOXIRI: new trials by email Literature Review of FOLFOXIRI trials Research Report on FOLFOXIRI
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CtDNA in Adjuvant Chemotherapy of Stage III Colon Cancer (REVISE Trial) FOLFOXIRI, XELOX - Colon Cancer | Phase 2 | Recruiting | West China Hospital | 60 | 2024-03-25 | 2024-12-12 |
| Circulating Tumor DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II-III FOLFOXIRI, CAPOX - Colorectal Neoplasms Malignant, Minimal Residual Disease | Phase 2 | Active not recruiting | Fundación para la Investigación del Hospital Clínico de Valencia | 45 | 2022-01-01 | 2026-09-15 |
| FOLFOXIRI Plus Cetuximab Versus FOLFOXIRI Plus Bevacizumab in Conversion Therapy of Right-sided Colon Cancer Liver Metastases Cetuximab, Bevacizumab, FOLFOXIRI - Liver Metastasis Colon Cancer | Phase 2 | Unknown | Fudan University | 160 | 2021-04-17 | 2021-04-06 |
| Organ Preservation Program Using Short-Course Radiation & FOLFOXIRI in Rectal Cancer FOLFOXIRI, FOLFOX regimen, XELOX - Rectal Cancer | Phase 2 | Completed | Stanford University | 38 | 2020-05-21 | 2025-02-25 |
| Neoadjuvant FOLFOXIRI Chemotherapy in Resectable Liver Metastasis of Colorectal Cancer FOLFOXIRI - Colorectal Neoplasms, Drug Therapy | Phase 2 | Unknown | China Medical University, China | 30 | 2018-05-01 | 2021-04-19 |
| Neoadjuvant FOLFOXIRI Chemotherapy in Patients With Locally Advanced Colon Cancer FOLFOXIRI - Colonic Neoplasms, Drug Therapy | Phase 2 | Unknown | China Medical University, China | 30 | 2018-04-01 | 2021-04-19 |
| Totally Neoadjuvant FOLFOXIRI + Short-course Radiation + XELOX in Patients With Locally Advanced Rectal Cancer FOLFOXIRI, Short-Course Radiation Therapy(5Gy*5), XELOX - Rectal Neoplasms, Drug Therapy | Phase 2 | Unknown | China Medical University, China | 30 | 2018-04-01 | 2021-04-14 |
| FOLFOXIRI Chemotherapy Alone as Neoadjuvant Treatment for Circumferential Radial Margin (CRM) Positive Rectal Cancer FOLFOXIRI - Rectal Cancer | Phase 2 | Withdrawn | Guangxi Medical University | 2017-08-11 | 2019-08-08 | |
| Chemotherapy Intensification in Patients With High Lactate Dehydrogenase Values and Soluble Syndecan1 Levels FOLFOXIRI, FOLFOX, FOLFIRI - Metastatic Colorectal Cancer | Phase 2 | Terminated | Centre Hospitalier Universitaire de Besancon | 54 | 2017-08-04 | 2025-02-05 |
| Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer FOLFOXIRI - Rectal Cancer | Phase 2 | Unknown | RenJi Hospital | 100 | 2016-11-01 | 2018-01-03 |
| Neoadjuvant Triplet Chemotherapy Regimen in Patients With Locally Advanced Rectal Cancer FOLFOXIRI - Locally Advanced Rectal Cancer | Phase 2 | Completed | Aiping Zhou | 50 | 2016-02-06 | 2021-02-01 |
| FOLFOXIRI With or Without Bevacizumab as First-line Treatment for Unresectable Liver-only Metastatic Colorectal Cancer Patients With RAS Mutation-type FOLFOXIRI + Bevacizumab, FOLFOXIRI - Metastatic Colorectal Cancer | Phase 2 | Completed | Sun Yat-sen University | 138 | 2015-01-01 | 2026-05-22 |
| Neoadjuvant FOLFOXIRI Chemotherapy Alone for Locally Advanced Rectal Cancer FOLFOXIRI - Rectal Cancer | Phase 2 | Completed | Sun Yat-sen University | 100 | 2014-08-15 | 2021-04-14 |
| FOLFOXIRI Compared to FOLFOX in First Line Treatment of Metastatic Colorectal Cancer FOLFOXIRI, FOLFOX - Metastatic Colorectal Cancer | Phase 2 | Unknown | Sun Yat-sen University | 162 | 2014-04-01 | 2014-05-07 |
| FOLFOXIRI With or Without Cetuximab as First-line Treatment of Patients With Non-resectable Liver - Only Metastatic Colorectal Cancer FOLFOXIRI + Cetuximab, FOLFOXIRI - Metastatic Colorectal Cancer | Phase 2 | Completed | Sun Yat-sen University | 101 | 2014-02-01 | 2020-03-31 |
| FOLFOXIRI as Primary Treatment for Locally Advanced Pancreatic Cancer FOLFOXIRI - Pancreatic Carcinoma Stage III | Phase 2 | Completed | Azienda Ospedaliero, Universitaria Pisana | 50 | 2012-12-01 | 2015-01-30 |
| FOLFOXIRI With or Without Panitumumab in Metastatic Colorectal Cancer (VOLFI) FOLFOXIRI + Panitumumab, FOLFOXIRI - Metastatic Colorectal Cancer | Phase 2 | Completed | AIO-Studien-gGmbH | 93 | 2011-04-01 | 2023-06-15 |
Colorectal Neoplasms (6) · Rectal Neoplasms (6) · Colonic Neoplasms (3) · Neoplasm, Residual (1) · Neoplastic Cells, Circulating (1) · Pancreatic Neoplasms (1)
Sun Yat-sen University (4) · China Medical University, China (3) · AIO-Studien-gGmbH (1) · Aiping Zhou (1) · Azienda Ospedaliero, Universitaria Pisana (1) · Centre Hospitalier Universitaire de Besancon (1) · Fudan University (1) · Fundación para la Investigación del Hospital Clínico de Valencia (1) · Guangxi Medical University (1) · RenJi Hospital (1) · Stanford University (1) · West China Hospital (1)
China (12) · France (1) · Germany (1) · Italy (1) · Spain (1) · United States (1)
Yanhong Deng, M.D. (3) · Jingdong Zhang (2) · Aiping Zhou, Doctor (1) · Erqi L Pollom (1) · Ming Ye, Master (1) · Wen Zhang (1) · Yuzhou Qin (1)
PMID 31609637, PMID 35834598, PMID 37370032, PMID 38902952, PMID 39753246, PMID 42743885
2009 (1)